
Clinicians are advised to discuss reproductive risks and fertility preservation options with all cancer patients prior to initiating therapy to maximize future reproductive potential.

Joshua Fitch is the senior editor for Contemporary OB/GYN. He joined the brand in January of 2026, after being the senior editor of our sister publication, Contemporary Pediatrics, since March of 2023. Fitch graduated from Youngstown State University in Youngstown, Ohio, in 2020 with a degree in telecommunications and journalism. He started his career as a news and sports videographer before becoming an on-air sports anchor at the NBC-affiliated news station in Youngstown. Fitch briefly worked as a national content writer for a Chicago-based national television station before joining the Contemporary Pediatrics team. He can be reached at: [email protected].

Clinicians are advised to discuss reproductive risks and fertility preservation options with all cancer patients prior to initiating therapy to maximize future reproductive potential.

According to FLO Living, the Cycle Syncing Method resulted in 92% of participants reporting meaningful reductions in the number and intensity of PMS symptoms after 60 days.

Get caught up with Contemporary OB/GYN! This list helps you navigate our top stories from the week, all in one place.

An expert infectious disease panel discusses how recent federal vaccine schedule changes can impact maternal immunizations and potential repercussions.

Research indicates that LMWH prophylaxis effectively mitigates the high risk of pregnancy loss and reduced natural fecundity associated with protein S deficiency.

The Menopause Society reported new data from 68 health organizations that showed vaginal estrogen therapy does not elevate recurrence risk in survivors aged 18 to 51.

Results from the TITAN 2 study presented at SUFU 2026 demonstrate that the Altaviva ITNM system provides sustained reduction in UUI episodes and improved quality of life through 24 months.

Data published in npj Digital Medicine indicates that digital symptom checkers for endometriosis can reduce diagnostic delay by over 4 years and save more than $5,000 per patient.

The FDA has cleared a cloud-based AI tool that predicts delivery dates solely from ultrasound images.

Research published in The BMJ indicates that individuals vaccinated against HPV before age 17 experience a 79% reduction in invasive cervical cancer risk compared to unvaccinated peers.

Researchers reported that lidocaine did not affect POUR rates but enhanced early recovery metrics after SUI surgery.

A global analysis found significant disparities in magnesium sulfate use for preterm birth, particularly between higher- and middle-income countries.

A prospective observational study found that age did not independently affect bone mineral density response to romosozumab in postmenopausal women.

Get caught up with Contemporary OB/GYN! This list helps you navigate our top stories from the week, all in one place.

A cross-sectional study found that higher body fat percentage and other adiposity measures were inversely associated with endometriosis severity.

The updated Committee Statement reaffirmed the safety and benefits of influenza, COVID-19, Tdap, and RSV vaccines during pregnancy while addressing misinformation and disparities.

Women with endometriosis or adenomyosis face 10- to 11-year diagnostic delays, study finds.

Preeclampsia was associated with an elevated risk of early kidney damage, highlighting gaps in postpartum surveillance.

In this Q&A interview, Marie Anderson, MD, of Columbia University, highlights a study presented at SMFM 2026 linking abortion restriction and increased rates of maternal death in the United States.

The label changes to 6 menopausal HRTs "clarify risk considerations for these drugs," according to a statement from the FDA.

The Society for Maternal-Fetal Medicine has released updated checklists to guide evidence-based management of monochorionic twin pregnancies and reduce preventable complications.

If allowed by prescribers, patients can complete pregnancy tests outside of a medical setting, but must complete pre-treatment pregnancy tests in a medical setting, according to the FDA.

Addressing geographic inequities in maternal-fetal medicine care through workforce investment and policy reform is critical to improving pregnancy outcomes and reducing maternal deaths, according to SMFM.

Women who experienced menopause before age 50 had higher rates of MASLD and adverse metabolic outcomes, according to reasearch published in Diabetes Metabolism Research and Reviews.

Get caught up with Contemporary OB/GYN! This list helps you navigate our top stories from the week, all in one place.

A Chinese study found that menstrual blood HPV testing had a comparable diagnostic accuracy to clinician-collected cervical samples in detecting CIN2+ and CIN3+.

A new ACOG Committee Statement outlines how immigration status affects health outcomes and calls for enforcement-free health care settings.

ACOG continues to support maternal immunization against COVID-19, flu, and RSV amid growing public questions about vaccine safety during pregnancy.

Take a look back at any of our expert video interviews you may have missed from January 2026.

Take a quick look at everything you may have missed in January, from our latest video interviews to new clinical trial data to a FAQ on cervical cancer.